Studying a Genetic Mutation in Osteosarcoma
Working Toward an Immunotherapy for Osteosarcoma
Evaluating a Novel Immunotherapy in Dogs with Osteosarcoma
Researchers are investigating the effectiveness of a novel immunotherapy to help reduce metastatic disease (cancer spread) and prolong quality of life in dogs with osteosarcoma.
Looking for New Targeted Therapies for Osteosarcoma
Researchers will investigate the role of a signaling pathway in the progression of bone cancer in dogs and evaluate its potential as a new therapeutic target to help treat this disease.
Finding Solutions for Giant-Breed Dogs with Osteosarcoma
Assessing Immune Stimulation as a Potential Therapy for Osteosarcoma
This study will characterize the expression of toll-like receptors, which activate the immune system, in canine osteosarcoma cells to better determine the biological consequences associated with activating these receptors.
Evaluating a New Treatment for Canine Osteosarcoma
Evaluating the Effectiveness of an Adjunct Therapy in Dogs with Osteosarcoma
Researchers are evaluating the effectiveness of oral rapamycin as an adjunct, postsurgery therapy to combat cancer spread (metastasis) in client-owned dogs.
Determining How Overexpression of miR-9 Helps Osteosarcoma Spread
This study will provide a molecular framework for understanding the process of miR-9-driven tumor spread in canine osteosarcoma, thereby generating potential new targets for therapy to prevent or treat tumor spread in this devastating disease.